J H McCusker
Overview
Explore the profile of J H McCusker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
2157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lashkari D, DeRisi J, McCusker J, Namath A, Gentile C, Hwang S, et al.
Proc Natl Acad Sci U S A
. 1997 Dec;
94(24):13057-62.
PMID: 9371799
We have developed high-density DNA microarrays of yeast ORFs. These microarrays can monitor hybridization to ORFs for applications such as quantitative differential gene expression analysis and screening for sequence polymorphisms....
12.
Lashkari D, McCusker J, Davis R
Proc Natl Acad Sci U S A
. 1997 Aug;
94(17):8945-7.
PMID: 9256414
The recent ability to sequence whole genomes allows ready access to all genetic material. The approaches outlined here allow automated analysis of sequence for the synthesis of optimal primers in...
13.
Clemons K, Park P, McCusker J, McCullough M, Davis R, Stevens D
J Clin Microbiol
. 1997 Jul;
35(7):1822-8.
PMID: 9196202
We have previously described differences in phenotype and virulence among clinical and nonclinical isolates of Saccharomyces. To further characterize these isolates, a comparison of restriction fragment length polymorphism (RFLP) patterns...
14.
Na S, Hincapie M, McCusker J, Haber J
J Biol Chem
. 1995 Mar;
270(12):6815-23.
PMID: 7896828
The abundance of yeast plasma membrane H(+)-ATPase on the cell surface is tightly regulated. Modifier of pma1 (mop) mutants were isolated as enhancers of the mutant phenotypes of pma1 mutants....
15.
Byron J, Clemons K, McCusker J, Davis R, Stevens D
Infect Immun
. 1995 Feb;
63(2):478-85.
PMID: 7822013
We have previously determined the relative virulence of isolates of Saccharomyces cerevisiae on the basis of differences in proliferation and resistance to clearance in CD-1 mice. These infections were not...
16.
McCusker J, Clemons K, Stevens D, Davis R
Infect Immun
. 1994 Dec;
62(12):5447-55.
PMID: 7960125
Saccharomyces cerevisiae isolates have been shown previously to exhibit a high degree of variation in their ability to proliferate and persist in CD-1 mice (K.V. Clemons, J.H. McCusker, R. W....
17.
Clemons K, McCusker J, Davis R, Stevens D
J Infect Dis
. 1994 Apr;
169(4):859-67.
PMID: 8133102
Although considered nonpathogenic, Saccharomyces cerevisiae is being encountered more frequently in the clinical setting. To assess pathogenic potential, 13 clinical isolates, 10 nonclinical isolates, and 5 constructed strains of S....
18.
McCusker J, Clemons K, Stevens D, Davis R
Genetics
. 1994 Apr;
136(4):1261-9.
PMID: 8013903
Saccharomyces cerevisiae isolates from human patients have been genetically analyzed. Some of the characteristics of these isolates are very different from laboratory and industrial strains of S. cerevisiae and, for...
19.
Nelson S, McCusker J, Sander M, Kee Y, Modrich P, Brown P
Nat Genet
. 1993 May;
4(1):11-8.
PMID: 8513319
Genomic mismatch scanning (GMS) is a new method of genetic linkage analysis that does not require conventional polymorphic markers or gel electrophoresis. GMS is ideally suited to affected-relative-pair mapping. DNA...
20.
McCusker J, Davis R
Yeast
. 1991 Aug;
7(6):607-8.
PMID: 1767588
The use of proline as a nitrogen source causes hypersensitivity to 5-fluoro-orotic acid (5FOA) and allows up to 40-fold less of this drug to be used to select for the...